REGENXBIO Inc. Insider Trading for October 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENXBIO Inc. for October 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 102,072 | |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 64.42 | 100 | 6,442 | 0 | 100 to 0 (-100.00 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 63.67 | 5,446 | 346,747 | 100 | 5.5 K to 100 (-98.20 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 62.93 | 8,026 | 505,076 | 5,546 | 13.6 K to 5.5 K (-59.14 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.82 | 2,100 | 129,822 | 13,572 | 15.7 K to 13.6 K (-13.40 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.66 | 1,700 | 103,122 | 15,672 | 17.4 K to 15.7 K (-9.79 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.83 | 3,042 | 182,003 | 17,372 | 20.4 K to 17.4 K (-14.90 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 58,472 | |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 62.67 | 90 | 5,640 | 17,669 | 17.8 K to 17.7 K (-0.51 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 62.00 | 3,410 | 211,420 | 17,759 | 21.2 K to 17.8 K (-16.11 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 61.22 | 1,500 | 91,830 | 21,169 | 22.7 K to 21.2 K (-6.62 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 22,669 | 17.7 K to 22.7 K (+28.30 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 2,667 | 34,911 | 3,333 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 19.50 | 13,125 | 255,938 | 16,875 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 46,517 | 1,023,374 | 108,983 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 2,667 | 162,287 | 39,500 | 42.2 K to 39.5 K (-6.32 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 2,667 | 34,911 | 42,167 | 39.5 K to 42.2 K (+6.75 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 13,125 | 798,656 | 39,500 | 52.6 K to 39.5 K (-24.94 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 19.50 | 13,125 | 255,938 | 52,625 | 39.5 K to 52.6 K (+33.23 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 46,517 | 2,830,559 | 39,500 | 86 K to 39.5 K (-54.08 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 46,517 | 1,023,374 | 86,017 | 39.5 K to 86 K (+117.76 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 10,414 | 8,852 | 122,486 | |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 10,000 | 8,500 | 132,900 | |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.18 | 10,414 | 637,129 | 0 | 10.4 K to 0 (-100.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 10,414 | 8,852 | 10,414 | 0 to 10.4 K |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.25 | 100 | 6,025 | 0 | 100 to 0 (-100.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.54 | 7,000 | 416,780 | 100 | 7.1 K to 100 (-98.59 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 58.83 | 2,900 | 170,607 | 7,100 | 10 K to 7.1 K (-29.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 10,000 | 8,500 | 10,000 | 0 to 10 K |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 59.59 | 5,000 | 297,950 | 137,283 | 142.3 K to 137.3 K (-3.51 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 58.93 | 2,500 | 147,325 | 142,283 | 144.8 K to 142.3 K (-1.73 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 59.55 | 5,710 | 340,031 | 326,000 | 331.7 K to 326 K (-1.72 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 58.73 | 1,800 | 105,714 | 331,710 | 333.5 K to 331.7 K (-0.54 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 20,000 | 407,000 | 80,000 | |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 65.60 | 216 | 14,170 | 0 | 216 to 0 (-100.00 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 64.78 | 4,000 | 259,120 | 216 | 4.2 K to 216 (-94.88 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 63.73 | 12,284 | 782,859 | 4,216 | 16.5 K to 4.2 K (-74.45 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 62.79 | 3,500 | 219,765 | 16,500 | 20 K to 16.5 K (-17.50 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 20,000 | 407,000 | 20,000 | 0 to 20 K |